Urine TB-LAM is an affordable and rapid point-of-care test that has a sensitivity of 45% and specificity of 92% in patients with severe HIV-related immunosuppression (CD4 < 200 cells/mm3) in South Africa [22,23]. This evidence concerns the gene CD4 and tuberculosis.